Tech Company Financing Transactions

BioSapien Funding Round

BioSapien, operating out of Carlsbad, scored $5.5 million from Global Ventures and Dara Holdings.

Transaction Overview

Company Name
Announced On
12/12/2024
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Series A
Investors

Global Ventures (Lead Investor) (Noor Sweid)

Dara Holdings

Proceeds Purpose
This cash injection fuels the company's mission to transform cancer treatment through cutting-edge innovation.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
6076 Corte Del Cedro
Carlsbad, CA 92011
USA
Phone
Undisclosed
Email Address
Overview
BioSapien, founded in 2018, pioneers minimally invasive drug delivery platforms. Our signature MediChip� technology utilizes 3D printing to deliver targeted chemotherapy directly to a tumor site, minimizing the side effects of care. This biodegradable innovation offers sustained medication release for a variety of cancers and potentially other conditions.
Profile
BioSapien LinkedIn Company Profile
Social Media
BioSapien Company Twitter Account
Company News
BioSapien News
Facebook
BioSapien on Facebook
YouTube
BioSapien on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Khatija Ali
  Khatija Ali LinkedIn Profile  Khatija Ali Twitter Account  Khatija Ali News  Khatija Ali on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/12/2024: SkySQL venture capital transaction

 

Share this article

 


Where The Data Comes From

We document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary